Dendritic cell-based cancer vaccine;Dendritcellebaseret cancervaccine

Ugeskrift for Laeger

Volumn 168, Issue 14, 2006, Pages 1420-1423

  Burgdorf, Stefan K ^a   Claësson, Mogens H ^a   Rosenberg, Jacob ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CANCER TESTIS ANTIGEN; CD45 ANTIGEN; CYTOKINE; DENDRITIC CELL VACCINE; INTERFERON; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; CANCER VACCINE;

ANTIGEN PRESENTING CELL; CANCER; CANCER PATIENT; CANCER THERAPY; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; REVIEW; TREATMENT RESPONSE; TUMOR REGRESSION; VACCINATION; ARTICLE; DENDRITIC CELL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; T LYMPHOCYTE;

ANTIGENS, NEOPLASM; CANCER VACCINES; DENDRITIC CELLS; HUMANS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 33645751492     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Huber CH, Wolfel T. Immmunotherapy of cancer: from vision to standard clinical practice. J Cancer Res Clin Oncol 2004;130:367-74.
2. Vieweg J, Jackson A. Modulation of antitumor responses by dendritic cells. Springer Semin Immunopathol 2005;26:329-41.
3. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973;137:1142-62.
4. Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005;5:296-306.
5. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002;2:151-61.
6. Rodriguez A, Regnault A, Kleijmeer M et al. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat Cell Biol 1999;1:362-8.
7. Mocellin S, Rossi CR, Lise M et al. Colorectal Cancer Vaccines: Principles, Results, and Perspectives. Gastroenterology 2004;127:1821-37.
8. Cranmer LD, Trevor KT, Hersh EM. Clinical applications of dendritic cell vaccination in the treatment of cancer. Cancer Immunol Immunother 2004; 53:275-306.
9. Chakraborty NG, Chattopadhyay S, Mehrotra S et al. Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma. Hum Immunol 2004;65:794-802.
10. Markiewicz MA, Kast WM. Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes. Cancer Invest 2004;22:417-34.